Clinical Trial Update: Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir in Adults With Genotype 1a or Genotype 4 Chronic Hepatitis C Virus (HCV) Infection, With Severe Kidney Impairment or End Stage Kidney Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Ombitasvir/Paritaprevir/Ritonavir with or without Dasabuvir in adults with genotype 1a or 4 chronic hepatitis C and severe kidney imp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir (ombitasvir)
• Paritaprevir (paritaprevir)
• Ritonavir (Ritonavir)

Snippet

Sponsor: AbbVie | Conditions: Hepatitis C Virus (HCV) | Phase 3 | Status: COMPLETED | Results posted: 2017-12-04